NPCE
Neuropace Inc
14.00$
-1.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -14.0% | -18.5% | -41.5% | -20.3% | -8.2% | -22.3% | -33.2% | -8.9% | -7.1% | 1.9% | -26.7% | -17.1% | -11.4% | |
| 2.4% | 2.3% | 2.3% | 2.3% | 2.1% | 2.1% | 2.1% | 2.0% | 1.8% | 2.0% | 2.3% | 2.3% | 2.1% | |
| 14.7% | 13.1% | 14.0% | 13.2% | 12.3% | 12.1% | 11.7% | 13.7% | 9.6% | 9.8% | 10.3% | 10.1% | 9.9% | |
| 7.1% | -4.4% | -14.6% | -1.8% | 2.6% | -14.0% | -19.4% | 8.9% | -6.1% | -0.2% | -10.8% | -3.5% | -5.0% | |
| 0.1% | 0.2% | 0.6% | 0.3% | 0.5% | 0.2% | 0.2% | 0.7% | 0.1% | 0.4% | 0.5% | 0.5% | 0.4% | |
| 25.5% | 19.3% | 13.2% | 16.8% | 6.6% | 9.1% | -0.2% | -0.7% | -0.1% | -0.4% | -0.5% | -0.5% | -0.4% | |
| -0.2% | -0.2% | -3.6% | -0.4% | -0.3% | -0.4% | -220.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | -0.5% | 0.0% | – | – | – | |
| -0.2% | 45.6% | 0.4% | 2.6% | 13.8% | 4.0% | 93.7% | -8.1% | -0.9% | 2.4% | -0.8% | 5.2% | 1.4% | |
| 11.3% | 46.3% | -27.9% | -0.8% | 12.2% | -9.3% | 60.3% | -17.7% | -8.1% | 3.9% | -31.3% | -12.5% | -11.1% | |
| -14.1% | -18.7% | -42.1% | -20.6% | -8.7% | -22.5% | -33.4% | -9.6% | -7.2% | 1.5% | -27.3% | -17.6% | -11.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.